Welcome to our dedicated page for PRESSURE BIOSCIENCES news (Ticker: $PBIO), a resource for investors and traders seeking the latest updates and insights on PRESSURE BIOSCIENCES stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PRESSURE BIOSCIENCES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PRESSURE BIOSCIENCES's position in the market.
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) announces the expansion of its Uncle Bud’s Health & Wellness products with the introduction of Premium Collection nanoemulsified products processed using PBIO’s UltraShear Technology™. These products offer revolutionary bioavailability, fast onset, and effectiveness in various health & wellness categories. The company aims to leverage its innovative technology to penetrate new market sectors and drive significant revenue growth in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.05%
Tags
-
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) receives critical processor license for industrial hemp in MA, allowing the company to enhance production and manage anticipated purchase order increases with a West Coast partner. Uncle Bud's Health & Wellness experiences significant sales with its UltraShear-processed CBD product, leading to a successful launch of the Premium Collection. PBIO's Ultra Shear Technology™ platform demonstrates superior bioavailability, supported by a recent scientific study. The company's MA processing license enables it to expand into the CBD marketplace, signaling a focus on generating revenue from nanoemulsified products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.65%
Tags
-
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) reports significant growth and promising financial results following the acquisition of Uncle Bud’s Health & Wellness. Key highlights include a 60% surge in Amazon sales, a 16% increase in direct-to-consumer sales, a 13% growth in new DTC customers, a 138% surge in DTC subscriptions, a 142% increase in website traffic, and upcoming collaborations with high-profile celebrities and influencer campaigns. The introduction of a new Premium Collection processed with PBIO’s UltraShear™ nanoemulsification platform promises enhanced product capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.04%
Tags
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) announced the consolidation of its Boston area operations into a state-of-the-art manufacturing facility in Canton, MA. The new facility aims to enhance R&D capabilities, equipment development, and production, leading to improved efficiencies and cost savings for the Company's growth plans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) announces the acquisition of Uncle Bud’s and the launch of their UltraShear-processed Premium Collection, expected to generate $5 million in revenue in 2024 and potentially 5X more than historical annual revenue. The collection features nanoemulsified products processed with PBIO’s multi-patented UltraShear Technology, offering unparalleled speed of absorption and delivery of active ingredient dosing payload more efficiently.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.25%
Tags
-
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) expects a 3-fold increase in revenue to approximately $5 million by 2024, driven by the strategic acquisition of Uncle Bud’s and the introduction of new UltraShear processed nanoemulsion products. The Company plans to discuss the integration of Uncle Bud’s into PBIO and the expected significant revenue growth in a teleconference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.38%
Tags
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) has closed its acquisition of natural health and wellness leader Uncle Bud’s in an all-stock transaction. The combined companies will introduce revolutionary new product capabilities across multiple major market sectors, expecting 2024 revenues of over $10 million, then accelerating in future years. The transaction is expected to be immediately accretive and a major accelerator to PBIO’s top line revenue growth, positioning the company to attract new growth investment and rapidly strengthen its balance sheet. PBIO's President and CEO forecasts a 5-fold leap forward in revenues to over $10 million in 2024, with plans for revolutionary impact and sales growth across nutraceuticals, cosmeceuticals, skincare, food/beverage, agrochemical, and other major markets in the following years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.52%
Tags
-
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) receives an Open Order Agreement for the purchase of over 10,000 bottles of its Nano-CBD Topical Spray in 2024, valued at over $300,000. VICAR Holdings, LLC, a newly formed company with a focus on health and wellness, will be the purchaser. The product will be sold as PrescriptionGrade Nano-CBD and will be the first product available through VICAR's online store. The product is manufactured using PBIO's patented UltraShear™ technology, providing ultrafast speed of action and unprecedented effectiveness. The initial product shipment is expected in the coming weeks, with subsequent shipments to follow quickly thereafter. The contract with VICAR Holdings is seen as a positive indication of the company's momentum in 2024, following the strategic Uncle Bud's announcements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.26%
Tags
-
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) has announced the acquisition of Uncle Bud’s, a renowned natural health and wellness leader, and the beginning of summer season order filling with one of the globe’s leading retailers. The company shipped a significant $252,000 order for its popular Sunburn Soother, leveraging PBIO’s patented UltraShearTM technology platform for nanoemulsification processing to improve products. The combined company plans to become a leading provider of topicals and other consumer products containing oil-based active ingredients, with a focus on delivering unparalleled speed of action and effective payload bioavailability in preservative-free products with unprecedented long-term stability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.63%
Tags
Rhea-AI Summary
Pressure BioSciences, Inc. (PBIO) to Acquire Uncle Bud’s, Merging Scientific Capabilities and Natural Health and Wellness Leadership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16%
Tags
PRESSURE BIOSCIENCES
OTC:PBIO
PBIO Rankings
PBIO Stock Data
7.63M
21.57M
1.14%
0.03%
2.38%
Testing Laboratories
Professional, Scientific, and Technical Services
United States of America
South Easton
About PBIO
we are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology ("pct"). pct uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.